Impact of 1st and subsequent cycle pegfilgrastim on neutropenic events in patients receiving myelosuppressive chemotherapy: Preliminary results of FIRST, a prospective community-based study

Autor:	B. Ding, B. Mirtsching, M. Rader, Roger Dansey, Howard Ozer
Rok vydání:	2005
Předmět:	Cancer Research Myelosuppressive Chemotherapy medicine.medical_specialty Schedule Chemotherapy business.industry Registry study medicine.medical_treatment Community based study Oncology Medicine In patient business Intensive care medicine Pegfilgrastim medicine.drug
Zdroj:	Journal of Clinical Oncology. 23:8118-8118
ISSN:	1527-7755 0732-183X
DOI:	10.1200/jco.2005.23.16_suppl.8118
Popis:	8118 Background: Most alterations to chemotherapy (CT) dose and schedule are due to neutropenic events, which mostly occur in the 1st cycle. The ANC registry study has prospectively documented 1st ...
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::6db6c2616ce844b8fbccb4d55e09f8b8 https://doi.org/10.1200/jco.2005.23.16_suppl.8118 Zobrazit plný text záznamu